Table 4.
QALYs | Costs | ICER | |
nsNSAID | 10.1678 | $10,096 | |
Celecoxib | 10.2982 | $14,151 | |
Net incremental | 0.1304 | $4,055 | $31,097 |
ICER, incremental cost-effective ratio; QALY, quality-adjusted life year; nsNSAID, nonselective nonsteroidal anti-inflammatory drugs.